F Tomaka

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. ncbi Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers
    F Tomaka
    Tibotec Inc, Yardley, PA, USA
    HIV Med 10:318-27. 2009

Detail Information

Publications1

  1. ncbi Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers
    F Tomaka
    Tibotec Inc, Yardley, PA, USA
    HIV Med 10:318-27. 2009
    ..Darunavir (TMC114) is a new HIV protease inhibitor (PI)...